Cargando…
P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431416/ http://dx.doi.org/10.1097/01.HS9.0000970768.50687.93 |
| _version_ | 1785091195502854144 |
|---|---|
| author | Fridberg, Gil Shragai, Tamir Melamed, Natan Trestman, Svetlana Vaxman, Iuliana Avivi, Irit Cohen, Yael |
| author_facet | Fridberg, Gil Shragai, Tamir Melamed, Natan Trestman, Svetlana Vaxman, Iuliana Avivi, Irit Cohen, Yael |
| author_sort | Fridberg, Gil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431416 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104314162023-08-17 P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM Fridberg, Gil Shragai, Tamir Melamed, Natan Trestman, Svetlana Vaxman, Iuliana Avivi, Irit Cohen, Yael Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431416/ http://dx.doi.org/10.1097/01.HS9.0000970768.50687.93 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Fridberg, Gil Shragai, Tamir Melamed, Natan Trestman, Svetlana Vaxman, Iuliana Avivi, Irit Cohen, Yael P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM |
| title | P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM |
| title_full | P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM |
| title_fullStr | P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM |
| title_full_unstemmed | P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM |
| title_short | P966: SMOLDERING MULTIPLE MYELOMA (MM) PROGRESSING TO ACTIVE MM DURING FOLLOW-UP: REDUCED BONE DISEASE AND IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL COMPARED TO DE-NOVO NEWLY DIAGNOSED MM |
| title_sort | p966: smoldering multiple myeloma (mm) progressing to active mm during follow-up: reduced bone disease and improved progression-free and overall survival compared to de-novo newly diagnosed mm |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431416/ http://dx.doi.org/10.1097/01.HS9.0000970768.50687.93 |
| work_keys_str_mv | AT fridberggil p966smolderingmultiplemyelomammprogressingtoactivemmduringfollowupreducedbonediseaseandimprovedprogressionfreeandoverallsurvivalcomparedtodenovonewlydiagnosedmm AT shragaitamir p966smolderingmultiplemyelomammprogressingtoactivemmduringfollowupreducedbonediseaseandimprovedprogressionfreeandoverallsurvivalcomparedtodenovonewlydiagnosedmm AT melamednatan p966smolderingmultiplemyelomammprogressingtoactivemmduringfollowupreducedbonediseaseandimprovedprogressionfreeandoverallsurvivalcomparedtodenovonewlydiagnosedmm AT trestmansvetlana p966smolderingmultiplemyelomammprogressingtoactivemmduringfollowupreducedbonediseaseandimprovedprogressionfreeandoverallsurvivalcomparedtodenovonewlydiagnosedmm AT vaxmaniuliana p966smolderingmultiplemyelomammprogressingtoactivemmduringfollowupreducedbonediseaseandimprovedprogressionfreeandoverallsurvivalcomparedtodenovonewlydiagnosedmm AT aviviirit p966smolderingmultiplemyelomammprogressingtoactivemmduringfollowupreducedbonediseaseandimprovedprogressionfreeandoverallsurvivalcomparedtodenovonewlydiagnosedmm AT cohenyael p966smolderingmultiplemyelomammprogressingtoactivemmduringfollowupreducedbonediseaseandimprovedprogressionfreeandoverallsurvivalcomparedtodenovonewlydiagnosedmm |